
What is Tirzepatide?
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist developed for laboratory research into incretin hormone pathways. This research compound allows scientists to study both receptor systems simultaneously in controlled experimental environments. Scientific investigations have documented its molecular interactions with pancreatic signaling, glucose homeostasis mechanisms, and metabolic pathway regulation, making it a valuable tool for understanding dual incretin receptor interactions in experimental research applications.
Chemical Structure of Tirzepatide
Tirzepatide is a synthetic dual incretin receptor agonist with the amino acid sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS. The compound incorporates non-proteinogenic amino acid residues (Aib: aminoisobutyric acid) and fatty acid modifications that enhance stability and extend half-life in experimental protocols. With a molecular formula of C₂₂₅H₃₄₈N₄₈O₆₈ and molecular weight of 4813.527 g/mol (PubChem CID: 156588324, CAS: 2023788-19-2), this research peptide demonstrates unique structural characteristics for investigating dual GIP/GLP-1 receptor pathway interactions. The peptide's synthetic modifications, including the C20 fatty acid conjugation, provide enhanced bioavailability and stability for extended laboratory research applications across various experimental conditions.
